mitomycin has been researched along with bismuth in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Autenrieth, M; Bruchertseifer, F; Morgenstern, A; Pfost, B; Saur, D; Schwaiger, M; Seidl, C; Senekowitsch-Schmidtke, R | 1 |
| Esmaeil, N; Labbaf, S; Varshosaz, J; Varzandeh, M | 1 |
2 other study(ies) available for mitomycin and bismuth
| Article | Year |
|---|---|
Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice.
Topics: Administration, Intravesical; Alpha Particles; Animals; Antibodies, Monoclonal; Bismuth; Cell Line, Tumor; ErbB Receptors; Female; Humans; Immunohistochemistry; Luciferases, Firefly; Luminescent Measurements; Mice; Mice, Nude; Mitomycin; Radioimmunotherapy; Radioisotopes; Time Factors; Tissue Distribution; Transfection; Treatment Outcome; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2009 |
Sodium-borohydride exfoliated bismuthene loaded with Mitomycin C for chemo-photo-radiotherapy of triple negative breast cancer.
Topics: Bismuth; Borohydrides; Doxorubicin; Humans; Hyperthermia, Induced; Mitomycin; Phototherapy; Sodium; Triple Negative Breast Neoplasms | 2023 |